Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison.

Journal Article (Journal Article;Review)

Cardiovascular disease is a leading cause of morbidity and mortality in individuals with type 2 diabetes mellitus. These high-risk patients benefit from aggressive risk factor management, with blood pressure and low-density lipoprotein-cholesterol treatment, glycemic control, kidney protection, and lifestyle intervention. There are several recommendation and guideline documents across cardiology, endocrinology, nephrology, and general medicine professional societies from the United States and Europe with recommendations for cardiovascular risk reduction in patients with type 2 diabetes mellitus. Although there are some noteworthy differences, particularly in risk stratification, low-density lipoprotein-cholesterol and blood pressure treatment targets, and the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, overall there is considerable alignment across recommendations from different professional societies.

Full Text

Duke Authors

Cited Authors

  • Kelsey, MD; Nelson, AJ; Green, JB; Granger, CB; Peterson, ED; McGuire, DK; Pagidipati, NJ

Published Date

  • May 10, 2022

Published In

Volume / Issue

  • 79 / 18

Start / End Page

  • 1849 - 1857

PubMed ID

  • 35512864

Pubmed Central ID

  • PMC8972581

Electronic International Standard Serial Number (EISSN)

  • 1558-3597

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2022.02.046


  • eng

Conference Location

  • United States